Washington update.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 910
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 1998 AND VI 33 AND IP 9
Results: 10
1
2
Albumin/hetastarch guideline targets appropriate use, results in reduced product expenditures.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 995
- Publication type:
- Article
3
Cost savings from a midazolam to lorazepam therapeutic interchange program.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 905
- Publication type:
- Article
4
Measuring health-related quality of life: An introduction to survey instruments.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 897
- By:
- Publication type:
- Article
5
What to do when use of vancomycin is not recommended: Alternative therapeutic approaches for...
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 886
- Publication type:
- Article
6
Vancomycin utilization guidelines and restriction policies: A review.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 882
- By:
- Publication type:
- Article
7
Diabetes mellitus therapy: Evaluating the role of the newer antidiabetic agents.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 858
- By:
- Publication type:
- Article
8
Focus on quinupristin/dalfopristin: An investigational streptogramin antibiotic for the treatment...
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 841
- By:
- Publication type:
- Article
9
News capsules.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 836
- Publication type:
- Article
10
FDA NEW MOLECULAR ENTITIES.
- Published in:
- Formulary, 1998, v. 33, n. 9, p. 831
- Publication type:
- Article